Beijing Aosaikang Pharmaceutical News

Osecon (002755): Early-stage players have BIC potential as profit increased month-on-month

Changjiang SecuritiesNov 14 20:32

Osecon (002755): Innovation and transformation have given rise to new life for established pharmaceutical companies

gtjaSep 23 15:56

Osecon (002755): The light boat has passed Wanzhongshan and set sail for innovative medicine

Swhy ResearchSep 20 00:00

Osecon (002755): The impact of existing business has bottomed out, and the innovation pipeline is progressing smoothly in clinical practice

長江證券Sep 15 00:00

Osecon (002755): Reversing losses year over year in the first half of the year, combining simulation and development

Sep 3 00:00

Osecon (002755): Steady increase in sales

Sep 1 00:00

Osecon (002755) First Coverage Report: Gathering shortages are gradually bottoming out, and innovation and transformation are about to usher in gains

guoyuan securitiesJun 2 00:00

Osecon (002755): Waiting for breakthroughs in innovation-driven transformation

Mar 11 19:02

Osecon (002755): The impact of generic drug collection has bottomed out, and the innovative drug pipeline will enter the harvest period

Dec 16, 2023 00:00

Osecon (002755): The acquisition of Weidecang Incident Landing Pharmaceutical Devices Collaborates to Enhance Competitiveness in the Digestive Field

國海證券May 6, 2021 00:00

Osecon (002755) incident review: Maltol iron capsules with excellent Q1 performance were successfully approved and clinical marketing is expected quickly

國海證券Mar 29, 2021 00:00

Osecon (002755): A series of surprises after collaborating with Pharmaceutical Mingkang New Drug to land an innovative drug pipeline

國海證券Mar 21, 2021 00:00

Osecon (002755) Incident Review: 2020 Performance Slightly Exceeds Expectations Subsidiary Patent Authorization Model Highlights Value of Innovative Platforms

國海證券Feb 21, 2021 00:00

Comment on the Osaikang (002755) event: the second domestic anti-tumor drug temozolomide for injection was approved by PPI leader to expand its multi-product line for accelerated growth.

國海證券Jan 21, 2021 00:00

Osecon (002755) In-depth Report: PPI's Leading Multi-Product Line Expansion Enters Accelerated Growth, New First-tier Pharmaceutical Group Innovation Force Rises

國海證券Oct 28, 2020 00:00

Osaikang (002755): significant recovery of results in the third quarter, R & D and steady progress in the future

天風證券Oct 26, 2020 00:00

Osaikang (002755): affected by the epidemic in the first half of the year, the performance declined compared with the same period last year, Q2 improved and was optimistic about the company's long-term development.

天風證券Aug 26, 2020 00:00

Osaikang (002755): high-end first imitation + innovative drugs blossom on domestic PPI leading stars shine

天風證券May 10, 2020 00:00

Oriental New Star (002755): the performance inflection point has come to actively seek business transformation.

天風證券Apr 21, 2017 00:00

东方新星(002755)调研简报：行业低谷 未来可期

東興證券Jul 27, 2016 00:00